Medtronic Reports First Quarter Financial Results

Go back to Medtronic Reports First Quarter Financial Results

Medtronic, Inc. (MDT) PT Lowered to $92 at Oppenheimer

August 23, 2017 9:42 AM EDT

Oppenheimer lowered its price target on Medtronic, Inc. (NYSE: MDT) to $92.00 (from $93.00) while maintaining a Outperform rating.

... More